The use of telehealth skyrocketed during the COVID-19 pandemic as consumers were forced to find alternatives to seeing doctors in person. According to the Office of the National Coordinator for Health Information Technology (ONC), telemedicine use among office-based doctors increased nearly six-fold after the start of the pandemic.
This movement toward virtual healthcare was largely viewed as successful, with more than 80 percent of doctors claiming that they planned to continue using telehealth even after the pandemic ended, according to a survey conducted by the ONC.
Nevertheless, we’ve heard lots of talk about telehealth policy from federal lawmakers, but action to make these policies permanent has been sparse, creating much uncertainty around this policy at the federal level.
As we approach the end of 2023, I thought I’d briefly review where things stand in Congress on the issue of telehealth and how we got here.
One of the areas of telehealth use that flourished during the pandemic was the prescribing of controlled substances, which was prohibited via telehealth prior to the public health emergency (PHE). It also serves as a good example of how far telehealth has come, or not come.
According to a recent study, expanded telehealth use reduces the risk of opioid overdoses and improves access to opioid use disorder treatment. But following the pandemic, the Drug Enforcement Agency (DEA) unfortunately planned to revert to its pre-pandemic policy of prohibiting virtual prescribing of these and other controlled substances.
Correspondingly, in May, the DEA only reversed its proposed ban on telehealth prescriptions of controlled substances after receiving nearly 40,000 comments arguing against the prohibition.
Instead, the DEA’s temporary rule extended pandemic flexibilities in prescribing controlled substances until Nov. 11, just 9 days ago. The rule also allotted an additional one-year grace period, to November 2024 to give providers time to meet an in-person exam requirement for controlled substance prescribing.
Did this do enough though? It seems like regulators simply kicked the ball a bit further down the road and will have to address the issue again in a year.
To their credit, last month the DEA and U.S. Department of Health and Human Services (HHS) announced they would be extending the temporary prescribing flexibilities for controlled substances through the end of 2024. But still, this is another band-aid for a problem that needs a permanent fix.
Apart from prescribing, the following month, in June, the CONNECT for Health Act of 2021 was introduced in Congress, which would codify COVID-era virtual care flexibilities by permanently removing geographic restrictions on telehealth, expanding originating sites to include the home, and eliminating the six-month in-person visit requirement for mental healthcare via telehealth.
The bill was first introduced in the Senate, with 60 bipartisan cosponsors, and soon after, similar companion legislation was introduced in the House. However, neither bill has moved since that time, nor does either bill have a place on any congressional to-do lists before year-end.
We now arrive at last Tuesday, when a Senate subcommittee on healthcare issues met for a hearing on the future of telehealth. During the hearing, subcommittee members again conveyed bipartisan support for making certain telehealth flexibilities permanent, including those regarding prescriptions of certain controlled substances.
Proponents of making these changes permanent emphasized their utility in enhancing access to care and stressed that action sooner rather than later is vital to prevent uncertainty in the industry, while others expressed concern that more flexibility could give certain providers an unfair competitive advantage. But again, no action outside of extending cutoff dates.
A senior vice president at the American Telemedicine Association has been quoted as claiming that 2024 is “shaping up to be the Super Bowl for telehealth.” To that, I say, we’ll have to wait and see whether it’s a dud or one for the ages, but with so much at stake for providers, patients, and the industry at large, I’ll be watching closely regardless and suggest you do the same.
EDITOR’S NOTE: Artificial intelligence was utilized for structural refinement and grammatical editing. All analyses, interpretations, and opinions expressed in this article are solely those of
Today is Mardi Gras, which is French for “Fat Tuesday.” It is the last day before lent starts tomorrow, Ash Wednesday. This got me thinking
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
